Conferences – Confesercenti Partner http://confesercentipartner.com/ Fri, 08 Oct 2021 22:05:20 +0000 en-US hourly 1 https://wordpress.org/?v=5.8 http://confesercentipartner.com/wp-content/uploads/2021/05/confesercenti-partner-icon-150x150.png Conferences – Confesercenti Partner http://confesercentipartner.com/ 32 32 Notes, injury updates from Seahawks press conferences after landslide loss to Rams http://confesercentipartner.com/notes-injury-updates-from-seahawks-press-conferences-after-landslide-loss-to-rams/ http://confesercentipartner.com/notes-injury-updates-from-seahawks-press-conferences-after-landslide-loss-to-rams/#respond Fri, 08 Oct 2021 21:44:51 +0000 http://confesercentipartner.com/notes-injury-updates-from-seahawks-press-conferences-after-landslide-loss-to-rams/

Thursday night was a disaster for the Seahawks, as they fell to 2-3 while losing starting quarterback Russell Wilson to a finger injury. We haven’t heard from Russ after the game, but here’s what you need to know from the press conferences with Pete Carroll, Quandre Diggs, Tyler Lockett and Geno Smith.

Let’s start with the most important news: Pete Carroll’s updates on Russell Wilson’s finger injury.

We’ve received a few more updates on Pete Carroll’s injuries on wide receivers Penny Hart and Gerald Everett.

Quandre Diggs was fuming about the Seahawks’ defensive performance after the game. The Seahawks have allowed over 450 yards in four straight games, becoming the fourth team since merger to do so. No team has ever allowed 450 yards in five straight games, and no team has ever won more than six games in a season after enjoying a four-game streak.

Despite the terrible defensive performance, the Seahawks still had a chance to win late, but Geno Smith threw a late interception on a bad no-call for pass interference. Tyler Lockett claimed responsibility for the play.

I’ll try to end Thursday’s press conference notes with a few positives here. Michael Dickson had a cool double punt, and Geno Smith looked like he was ready for NFL football.

Let’s move on to some updates on Pete Carroll’s Friday presser injuries.

Carroll was also on 710ESPN Seattle this morning to talk about Russell Wilson’s injury and last night’s game.

Here’s a little more on the implications of Carroll’s description of the injury:

]]>
http://confesercentipartner.com/notes-injury-updates-from-seahawks-press-conferences-after-landslide-loss-to-rams/feed/ 0
SELLAS Life Sciences will participate in the next conferences in October 2021 http://confesercentipartner.com/sellas-life-sciences-will-participate-in-the-next-conferences-in-october-2021/ http://confesercentipartner.com/sellas-life-sciences-will-participate-in-the-next-conferences-in-october-2021/#respond Thu, 07 Oct 2021 13:14:00 +0000 http://confesercentipartner.com/sellas-life-sciences-will-participate-in-the-next-conferences-in-october-2021/

NEW YORK, Oct. 07, 2021 (GLOBE NEWSWIRE) – SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), an advanced-stage clinical biopharmaceutical company focused on the development of novel immunotherapies anticancer drugs for a wide range of indications, Angelos Stergiou, MD, ScD. hc, president and ceo of SELLAS, will attend two upcoming conferences:

  • The Laguna Biotech 2021 CEO Forum will be held at the Montage Laguna Beach Hotel in Laguna Beach, California, October 10-12, 2021.

  • AGP / Alliance Global Partners Biotech & Specialty Pharma conference to be held virtually on Wednesday, October 13, 2021.

For more information on conferences or to schedule a one-to-one meeting with SELLAS management, please contact your representative directly or email AGP / Alliance Global Partners at agpevents@allianceg.com, or at KCSA Strategic Communications at SELLAS @ kcsa.com.

About SELLAS Life Sciences Group, Inc.
SELLAS is an advanced clinical biopharmaceutical company focused on the development of novel cancer immunotherapeutics for a wide range of indications. SELLAS ‘lead product candidate, galinpepimut-S (GPS), is licensed by Memorial Sloan Kettering Cancer Center and targets the WT1 protein, which is found in a variety of tumor types. GPS has potential both as monotherapy and in combination to treat a wide range of hematologic malignancies and solid tumor indications. SELLAS ‘second product candidate, nelipepimut-S (NPS), is a cancer immunotherapy directed against HER2 that can treat patients with early-stage breast cancer with low to intermediate HER2 expression, also known as the name HER2 1+ or 2+, which includes patients with triple negative breast cancer (TNBC), depending on the standard of care.

For more information on SELLAS, please visit www.sellaslifesciences.com.

Investor contacts
Allison soss
KCSA strategic communication
212,896,1267
SELLAS@kcsa.com

Media contacts
Raquel cona
KCSA strategic communication
212.896.1204
SELLAS@kcsa.com

]]>
http://confesercentipartner.com/sellas-life-sciences-will-participate-in-the-next-conferences-in-october-2021/feed/ 0
CO law enforcement receives lesson on drone safety at national conference in Bend http://confesercentipartner.com/co-law-enforcement-receives-lesson-on-drone-safety-at-national-conference-in-bend/ http://confesercentipartner.com/co-law-enforcement-receives-lesson-on-drone-safety-at-national-conference-in-bend/#respond Thu, 07 Oct 2021 00:38:45 +0000 http://confesercentipartner.com/co-law-enforcement-receives-lesson-on-drone-safety-at-national-conference-in-bend/

(Update: added information and video)

Day 2 of Law Enforcement Drone Association National Conference kicks off in Bend

BEND, Ore. (KTVZ) – More than 40 law enforcement agencies are gaining first-hand drone safety experience this week at a national conference in Bend.

The Law Enforcement Drone Association is hosting its second annual sold-out national conference this week at the Christian Life Center. Law enforcement officers are learning “best practices and standardization of drone use in public safety,” the organization said.

Brandon Karr, a Texas police officer and LEDA member, told NewsChannel 21 that the organization wanted to expose legal agencies to the latest drone technologies, but the ultimate goal was to turn LEDA training courses into a standardized practice for all law enforcement agencies.

“We’re trying to develop this into the leading standard that every agency is going to use for basic pilot proficiency,” Karr said.

At the Bend Police Department, drones have been in use since 2016. The department has nine certified pilots, according to Sgt. Tom Pine, who is also a member of the LEDA board of directors.

“We use them for missing persons and search and rescue missions,” Pine said. “We are able to choose the right drone for the right scenario. “

As drones become more ubiquitous in law enforcement agencies, Karr said they are creating a safer environment not only for police but also for communities.

“Drones offer a perspective that we normally wouldn’t have,” Karr said. “It’s a huge benefit for the community… to implement technologies to provide a safer community.”

Law enforcement officers receive classroom instruction, then learn outdoor flight scenarios. Other items on the agenda include risk mitigation and liability, FAA updates, and night flight procedures. The conference will continue for two more days.

]]> http://confesercentipartner.com/co-law-enforcement-receives-lesson-on-drone-safety-at-national-conference-in-bend/feed/ 0 Mindset Pharma to Present at KCSA Psychedelics Virtual Investor Conference on October 14 http://confesercentipartner.com/mindset-pharma-to-present-at-kcsa-psychedelics-virtual-investor-conference-on-october-14/ http://confesercentipartner.com/mindset-pharma-to-present-at-kcsa-psychedelics-virtual-investor-conference-on-october-14/#respond Wed, 06 Oct 2021 11:00:00 +0000 http://confesercentipartner.com/mindset-pharma-to-present-at-kcsa-psychedelics-virtual-investor-conference-on-october-14/

Posted: October 6, 2021 at 7 a.m. EDT|Update: 1 hour ago

TORONTO, October 6, 2021 / PRNewswire / – Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company“), a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic drugs to treat neurological and psychiatric disorders with unmet medical needs, today announced that Jacques Lanthier, CEO of Mindset, will attend the KCSA Psychedelics Investor Conference to be held at VirtualInvestorConferences.com on October 13-14, 2021.

(PRNewsfoto / VirtualInvestorConferences.com)

M. Lanthier will present live on Thursday October 14e To 10:00 a.m.ET. Register to attend here.

For more information about the conference or to schedule a one-to-one meeting with the Mindset leadership team, please contact KCSA Strategic Communications at MindSet@kcsa.com.

About Virtual Investor Conferences®
Virtual Investor Conferences (VIC) is the premier, exclusive investor conference series that provides an interactive forum for publicly traded companies to meet and present directly with investors.

A real-time solution for investor engagement, Virtual Investor Conferences is part of OTC Market Group’s suite of investor relations services specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Virtual Investor Conferences combine cutting-edge conferencing and investor communication capabilities with a comprehensive global network of investor audiences.

Find out more about VIC and its events on www.virtualinvestorconferences.com.

About Mindset Pharma
Mindset Pharma Inc. is a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic drugs to treat unmet neurological and psychiatric conditions. Mindset was created to develop next-generation pharmaceutical actives that take advantage of the revolutionary therapeutic potential of psychedelic drugs. Mindset is developing several new families of new generation psychedelic compounds, as well as an innovative process for chemically synthesizing psilocybin as well as its own proprietary compounds.

For more information about Mindset, please visit our website at www.mindsetpharma.com.

Forward-looking information

This press release contains certain “forward-looking information” within the meaning of applicable securities laws. Forward-looking information is frequently characterized by words such as “plan”, “expect”, “plan”, “intend”, “believe”, “anticipate”, “estimate”, “power”, “Potential,” “” potential, “” proposed “and other similar words, or statements that certain events or conditions” may “or” will “occur. Such statements are only predictions. Forward-looking information is based on the opinions and estimates of management at the date the information is provided and is subject to various risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected information seeking Additional information regarding the risks and uncertainties associated with the Company’s business is contained under the heading “Risk Factors” in the Annual Information Form of the Company. e the Company for the financial year ended June 30, 2020 dated March 5, 2021. The forward-looking information included in this press release is made as of the date of this press release and the Company does not undertake to publicly update such forward-looking information to reflect new information, subsequent events or otherwise, except as required. by applicable law.

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATORY SERVICE PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS COMMUNICATION.

View original content to download multimedia:

SOURCE VirtualInvestorConferences.com

The above press release has been provided courtesy of PRNewswire. The views, opinions and statements contained in the press release are not endorsed by Gray Media Group and do not necessarily state or reflect those of Gray Media Group, Inc.

]]>
http://confesercentipartner.com/mindset-pharma-to-present-at-kcsa-psychedelics-virtual-investor-conference-on-october-14/feed/ 0
MDI Biology Laboratory Hosts First African Turquoise Killifish Conference http://confesercentipartner.com/mdi-biology-laboratory-hosts-first-african-turquoise-killifish-conference/ http://confesercentipartner.com/mdi-biology-laboratory-hosts-first-african-turquoise-killifish-conference/#respond Tue, 05 Oct 2021 20:04:00 +0000 http://confesercentipartner.com/mdi-biology-laboratory-hosts-first-african-turquoise-killifish-conference/

The biennial event will serve as a focal point for the research community in the Americas

BAR HARBOR – While it is the elephants and other large animals that congregate in East African waterholes that catch the attention of safari enthusiasts, the most fascinating inhabitant of these ephemeral pools can be a small, guppy-like fish called the turquoise African killifish or ATK (Nothobranchius furzeri).

Also known as the “instant fish” due to its short lifespan, ATK grows, reproduces and ages during the four to six month window of the rainy season, an adaptation to its extreme habitat which makes it more difficult to find. made one of the shorter. existing living vertebrates.